Showing results (2541-2550 of 31,410) with videos related to

Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|September 2, 2009
Automated docking screens: a feasibility studyJohn J Irwin, Brian K Shoichet, Michael M Mysinger, et al.
Journal of Medicinal Chemistry|September 2, 2009
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligandsWilliam H Bisson, Daniel C Koch, Edmond F O'Donnell, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis of fluorinated brassinosteroids based on alkene cross-metathesis and preliminary biological assessmentBarbara Eignerová, Barbora Slavíková, Milos Budĕsínský, et al.
Journal of Medicinal Chemistry|September 2, 2009
Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screeningSandro Cosconati, Luciana Marinelli, Concettina La Motta, et al.
Journal of Medicinal Chemistry|July 1, 1990
Design and synthesis of highly potent and selective cyclic dynorphin A analoguesA M Kawasaki, R J Knapp, T H Kramer, et al.
Journal of Medicinal Chemistry|July 1, 1990
Synthesis and antiallergy activity of N-[2-(dimethylamino)ethyl]-4-aryl-1-piperazinecarboxamide derivativesD A Walsh, J B Green, S K Franzyshen, et al.
Journal of Medicinal Chemistry|March 31, 2010
Oxetanes in drug discovery: structural and synthetic insightsGeorg Wuitschik, Erick M Carreira, Björn Wagner, et al.
Journal of Medicinal Chemistry|March 31, 2010
Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonistBaihua Hu, Rayomand J Unwalla, Igor Goljer, et al.
Journal of Medicinal Chemistry|September 18, 2009
Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's diseaseMasahiro Ono, Rumi Watanabe, Hidekazu Kawashima, et al.
Pageof 3,141